Project Description

Strategy Inc. helped us to get a handle on an emerging therapeutic solution that provides a complete paradigm shift – a revolutionary, not evolutionary approach. A Clinical Assessment with global leaders confirmed several of our assumptions, and also uncovered different priorities that will drive our strategy. In addition, several alternative opportunities for positioning were unearthed. I am pleased with the work performed by Strategy Inc. Jim Broderick MD, Partner, Morgenthaler Ventures, Boston, Massachusetts

Morgenthaler Ventures, founded 40 years ago, with $2.5B under management, including $450M in their current fund is located on Sand Hill Road in Menlo Park. Their Life Sciences division invests in Medical Devices, Biopharmaceuticals, Therapeutics and more.